Ardsley Advisory Partners LP Has $5.94 Million Holdings in Surgery Partners, Inc. $SGRY

Key Points

• Ardsley Advisory Partners LP reduced its stake in Surgery Partners, Inc. by 7.5%, selling 20,200 shares and holding 250,000 shares valued at approximately $5.9 million.
• Equities analysts have set mixed ratings for Surgery Partners, with a consensus target price of $33.00 and several analysts issuing a "buy" rating due to recent earnings performance.
• Insider trading activity was noted as Director Teresa Deluca sold 20,018 shares, reducing her ownership by 30.71% to 45,173 shares valued just over $1 million.

Ardsley Advisory Partners LP cut its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 7.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 250,000 shares of the company's stock after selling 20,200 shares during the quarter. Ardsley Advisory Partners LP owned 0.20% of Surgery Partners worth $5,938,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after acquiring an additional 465 shares during the period. PNC Financial Services Group Inc. increased its stake in Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after buying an additional 542 shares during the period. AlphaQuest LLC boosted its position in shares of Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after purchasing an additional 559 shares in the last quarter. Mackenzie Financial Corp boosted its position in shares of Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock valued at $465,000 after purchasing an additional 599 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Surgery Partners by 0.3% during the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company's stock valued at $8,115,000 after purchasing an additional 926 shares in the last quarter.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of the stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the sale, the director owned 45,173 shares of the company's stock, valued at $1,027,234.02. This represents a 30.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.70% of the stock is currently owned by corporate insiders.

Surgery Partners Price Performance

Shares of SGRY traded down $0.31 during trading hours on Monday, hitting $22.20. The stock had a trading volume of 223,439 shares, compared to its average volume of 1,393,708. The company's fifty day moving average is $22.48 and its two-hundred day moving average is $22.66. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. Surgery Partners, Inc. has a 52 week low of $18.87 and a 52 week high of $33.90. The stock has a market capitalization of $2.85 billion, a price-to-earnings ratio of -15.50 and a beta of 1.76.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. During the same quarter in the prior year, the firm earned $0.21 EPS. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. On average, analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Analyst Ratings Changes

Several analysts recently commented on the stock. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a "buy" rating and a $28.00 price target for the company. Barclays decreased their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a report on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.